*Experimental: mutation (blue); functional region (cyan); located in the long functional sequence (lightblue)
*NES patterns: region with experimental evidence (red-orange-yellow); false positive region (gray)
# | candidates | id | start# | sequence | secondary | class | multi-pattern | diso | spotd | iup | loc_DISO | loc_CDD | beta |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | cand_D | Q8VIP2 | 1 | MARALADLSVNLQVPR     *      *     | CHHHHCCCCCCCCCCC | c1d-4 | multi | 0.924 | 0.881 | 0.386 | DISO | 0.0 | |
2 | cand_D | Q8VIP2 | 1 | XMARALADLSVNLQVPR      *      *     | CHHHHCCCCCCCCCCCC | c1c-AT-5-Nt | multi-selected | 0.926 | 0.881 | 0.399 | DISO | 0.0 | |
3 | cand_D | Q8VIP2 | 81 | SIDPTLTRLFECLSLAY      *      *     | CCCHHHHHHHHHHCEEC | c1c-AT-5 | multi | 0.079 | 0.06 | 0.14 | boundary | 0.0 | |
4 | cand_D | Q8VIP2 | 82 | IDPTLTRLFECLSLAY     *      *     | CCHHHHHHHHHHCEEC | c1a-4 | multi-selected | 0.073 | 0.056 | 0.131 | boundary | 0.0 | |
5 | cand_D | Q8VIP2 | 82 | IDPTLTRLFECLSLAY     *      *     | CCHHHHHHHHHHCEEC | c1d-4 | multi | 0.073 | 0.056 | 0.131 | boundary | 0.0 | |
6 | cand_D | Q8VIP2 | 83 | DPTLTRLFECLSLAY    *      *     | CHHHHHHHHHHCEEC | c1b-AT-4 | multi | 0.067 | 0.053 | 0.127 | boundary | 0.0 | |
7 | fp_D | Q8VIP2 | 241 | QLLDLDCFLSDISD                | CCCCCCCCCCCCCC | c3-4 | multi-selected | 0.744 | 0.768 | 0.313 | DISO | boundary|Atrophin-1 superfamily; | 0.0 |
8 | fp_D | Q8VIP2 | 241 | QLLDLDCFLSDISDTL                  | CCCCCCCCCCCCCCCC | c1aR-4 | multi-selected | 0.729 | 0.756 | 0.321 | DISO | boundary|Atrophin-1 superfamily; | 0.0 |
9 | fp_D | Q8VIP2 | 248 | FLSDISDTLFTMTQ                | CCCCCCCCCCCCCC | c3-4 | uniq | 0.745 | 0.655 | 0.333 | DISO | boundary|Atrophin-1 superfamily; | 0.0 |
10 | fp_D | Q8VIP2 | 285 | DLTPLQPSLDDFMEISD                   | CCCCCCCCCCCCCCCCC | c1c-5 | multi-selected | 0.866 | 0.82 | 0.51 | DISO | MID|Atrophin-1 superfamily; | 0.0 |
11 | fp_D | Q8VIP2 | 285 | DLTPLQPSLDDFME                | CCCCCCCCCCCCCC | c3-4 | multi-selected | 0.893 | 0.828 | 0.518 | DISO | MID|Atrophin-1 superfamily; | 0.0 |
12 | fp_D | Q8VIP2 | 434 | PLFSARFPFTTVPP                | CCCCCCCCCCCCCC | c3-AT | uniq | 0.966 | 0.956 | 0.538 | DISO | MID|Atrophin-1 superfamily; | 0.0 |
13 | fp_D | Q8VIP2 | 450 | GVSTLPAPTTFVPT                | CCCCCCCCCCCCCC | c3-AT | uniq | 0.982 | 0.975 | 0.778 | DISO | MID|Atrophin-1 superfamily; | 0.0 |
14 | fp_D | Q8VIP2 | 678 | IKLGFDTLHGLVSTLS                  | CCCCHHHHHCCCCCCC | c1aR-5 | multi-selected | 0.306 | 0.23 | 0.333 | DISO | boundary|Atrophin-1 superfamily; boundary|HLH; | 0.0 |
15 | fp_D | Q8VIP2 | 681 | GFDTLHGLVSTLSA                | CHHHHHCCCCCCCC | c3-4 | multi-selected | 0.296 | 0.238 | 0.334 | DISO | boundary|Atrophin-1 superfamily; boundary|HLH; | 0.0 |
16 | fp_D | Q8VIP2 | 702 | KATTLQKTAEYILMLQQ                   | CCHHHHHHHHHHHHHHH | c1c-AT-4 | multi-selected | 0.319 | 0.258 | 0.335 | DISO | boundary|HLH; | 0.0 |
17 | fp_D | Q8VIP2 | 702 | KATTLQKTAEYILMLQ                  | CCHHHHHHHHHHHHHH | c1a-AT-4 | multi-selected | 0.317 | 0.261 | 0.332 | DISO | boundary|HLH; | 0.0 |
18 | fp_D | Q8VIP2 | 702 | KATTLQKTAEYILMLQ                  | CCHHHHHHHHHHHHHH | c1d-AT-4 | multi | 0.317 | 0.261 | 0.332 | DISO | boundary|HLH; | 0.0 |
19 | fp_D | Q8VIP2 | 705 | TLQKTAEYILMLQQ                | HHHHHHHHHHHHHH | c3-AT | multi | 0.306 | 0.248 | 0.323 | DISO | boundary|HLH; | 0.0 |
20 | fp_D | Q8VIP2 | 730 | LRDEIEELNAAINLCQ                  | HHHHHHHHHHHHHHHH | c1d-4 | uniq | 0.144 | 0.132 | 0.327 | DISO | boundary|HLH; | 0.0 |
21 | fp_D | Q8VIP2 | 744 | CQQQLPATGVPITH                | HHHHCCCCCCCCCC | c2-AT-4 | uniq | 0.282 | 0.161 | 0.342 | boundary | boundary|HLH; | 0.0 |
22 | fp_D | Q8VIP2 | 752 | GVPITHQRFDQMRD                | CCCCCCCCCCHHHH | c3-AT | uniq | 0.432 | 0.174 | 0.364 | boundary | boundary|HLH; | 0.0 |
23 | fp_D | Q8VIP2 | 777 | HNWKFWVFSILIRP                | CCCHHHHHHHHHHH | c2-4 | uniq | 0.038 | 0.018 | 0.018 | boundary | 0.0 | |
24 | fp_D | Q8VIP2 | 787 | LIRPLFESFNGMVS                | HHHHHHHHCCCCCC | c3-4 | uniq | 0.181 | 0.034 | 0.086 | boundary | 0.0 | |
25 | fp_D | Q8VIP2 | 831 | SLRQLSTSTSILTD                | HHHHHHCCCCCCCC | c3-AT | uniq | 0.214 | 0.128 | 0.306 | boundary | 0.0 |
*candidates: NES candidates and false positives annotated with "cand" and "fp", respectively;
                if the segment is located in the disordered or boundary region, flagged with "D"; if the segment is located in the ordered region, flagged with "O";
                if the segment's beta-strand content is over 0.5, flagged with "beta".
*sequence: Hydrophobic positions are colored in red. The positions with the experimental evidence is marked with '*' (mutation) and '+' (functional sequence in NESdb or sites in validNES).
                The positions with '.' are for the region annotated in the long (more than 25 residues) functional sequence or site.
*multi-pattern: the consensus pattern is unique or multiple within the region (if the start# difference is less than 5, the segments are considered to be the same region)
*diso: average DISOPRED3-predicted disorder propensity for the segment
*spotd: average SPOT-Disorder-predicted disorder propensity for the segment
*iup: average IUPRED2A-predicted disorder propensity for the segment
*loc_DISO: location of the segment with respect to the ordered/disordered regions
*loc_CDD: location of the segment with respect to the conserved region annotated in the Conserved Domain Database (CDD)
*beta: beta-strand content in the middle of the segment